Sign in

CIK 0001740279 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

IN8BIO, INC.

Sign in to watch
Ticker
INAB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
825462585
Phone
(646) 600-6438
Business address
EMPIRE STATE BUILDING, 350 5TH AVENUE, SUITE 5330, NEW YORK, NY, 10118
Former names
Incysus Therapeutics, Inc.
  1. 4 Insider Changes in Ownership
  2. 4 Insider Changes in Ownership
  3. 4 Insider Changes in Ownership
  4. 4 Insider Changes in Ownership
  5. 4 Insider Changes in Ownership
  6. 4 Insider Changes in Ownership
  7. 4 Insider Changes in Ownership
  8. 4 Insider Changes in Ownership
  9. 8-K Event Other events
  10. 8-K Event Other events
  11. EFFECT Other Notice of Effectiveness
  12. 424B3 Offering Prospectus
  13. 10-Q Report Quarterly Report
  14. 8-K Event Results of operations
  15. CORRESP Other Correspondence Between Filers and SEC Staff
  16. UPLOAD Other SEC-generated Letter
  17. S-3 Offering Registration Statement
  18. D Other Notice of Sales of Unregistered Securities
  19. 4 Insider Changes in Ownership
  20. 4 Insider Changes in Ownership

Page 7 of 21 · 412 filings